Effect of utilization policies for fluoroquinolones: a pilot study in nova scotia hospitals.

about

Effect of utilization policies for fluoroquinolones: a pilot study in nova scotia hospitals.

Item

http://www.wikidata.org/entity/Q39210974

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Effect of utilization policies ...... tudy in nova scotia hospitals.

@en

Effect of utilization policies ...... tudy in nova scotia hospitals.

@nl

type

Item

label

Effect of utilization policies ...... tudy in nova scotia hospitals.

@en

Effect of utilization policies ...... tudy in nova scotia hospitals.

@nl

prefLabel

Effect of utilization policies ...... tudy in nova scotia hospitals.

@en

Effect of utilization policies ...... tudy in nova scotia hospitals.

@nl

P1476

Effect of utilization policies ...... tudy in nova scotia hospitals.

@en

P2093

Andrea J Kent

http://www.w3.org/2001/XMLSchema#string

B Lynn Johnston

http://www.w3.org/2001/XMLSchema#string

Ingrid S Sketris

http://www.w3.org/2001/XMLSchema#string

Ryan B Sommers

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

Gatifloxacin.

Antibiotic use in a Canadian Province, 1995-1998.

Drug utilization reviews of oral quinolone, cephalosporin, and macrolide use in nonacute care: a systematic review.

Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital.

Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999.

Is more than one quinolone needed in clinical practice?

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?

P304

12-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4212/CJHP.V62I1.112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223960640

http://www.w3.org/2001/XMLSchema#string

P698

22478860

http://www.w3.org/2001/XMLSchema#string

P932

2826907

http://www.w3.org/2001/XMLSchema#string